Evidence map›Paper›PMID 30375983›Full record

ArticleAging2018

Longitudinal changes in leukocyte telomere length and mortality in elderly Swedish men.

Xiaotian Yuan, Magnus Kronström, Mai-Lis Hellenius, Tommy Cederholm, Dawei Xu, Per Sjögren

Abstract read
In one paragraph

Article in Aging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Time Spent Jogging/Running and Biological Aging in 4458 U.S. Adults: An NHANES Investigation.International journal of environmental research and public health · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Implications of risk conferred by 5p15.33 loci genetic variants; human telomerase reverse transcriptase rs2736098 and rs2736100 in predisposition of bladder cancer.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Telomere-related Markers for Cancer.Current topics in medicinal chemistry · 2020
    Review
  13. Review
  14. Article
  15. Observational
  16. Review
  17. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiaotian Yuan *Department of Medicine, Division of Hematology, and Center for Molecular Medicine, Karolinska Institutet and Karolinska University Hospital Solna, SE-171 76 Stockholm, Sweden.
Magnus Kronström *Department of Public Health and Caring Sciences, Unit of Clinical Nutrition and Metabolism, Uppsala University, Uppsala, Sweden.
Mai-Lis HelleniusKarolinska Institutet, Department of Medicine, Karolinska University Hospital, Solna, SE-171 76 Stockholm, Sweden.
Tommy CederholmDepartment of Public Health and Caring Sciences, Unit of Clinical Nutrition and Metabolism, Uppsala University, Uppsala, Sweden.
Dawei XuDepartment of Medicine, Division of Hematology, and Center for Molecular Medicine, Karolinska Institutet and Karolinska University Hospital Solna, SE-171 76 Stockholm, Sweden.
Per SjögrenDepartment of Public Health and Caring Sciences, Unit of Clinical Nutrition and Metabolism, Uppsala University, Uppsala, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Telomere length (TL) is considered an indicator of aging and age-related diseases, but longitudinal studies on TL changes and mortality are few. We therefore analyzed TL and longitudinal changes in TL in relation to all-cause, cardiovascular, and cancer mortality in 247 elderly Swedish men. TL was determined by the qPCR method at ages 71 and 81 and subsequent mortality cases were identified from the Swedish cause-of-death registry. Cox proportional hazard ratios were calculated during a mean follow-up of 7.4 years, during which 178 deaths occurred. Short telomeres at baseline was strongly associated with mortality risks, with a 40 to 70% increased risk of all-cause mortality, and a 2-fold increased risk of cancer mortality. Longitudinal changes in TL revealed shortening in 83% of individuals, whilst 10% extended their telomeres. TL attrition did not predict all-cause or cancer mortality, but we found a 60% decreased risk for cardiovascular mortality in those who shortened their telomeres. Our data show an increased risk of mortality in individuals with short baseline telomeres, but no relations to all-cause, and cancer mortality for changes in TL. Intriguingly, our data indicate lower risk of cardiovascular mortality with shortening of telomeres. The latter should be interpreted cautiously.

Indexed as

LeukocytesTelomereTelomere ShorteningAgedAged, 80 and overAge FactorsAgingCardiovascular DiseasesCause of DeathHumansLongitudinal StudiesMaleNeoplasmsRisk AssessmentRisk FactorsSex Factorscause-specific mortalitycohort studylongitudinal changesmortalitytelomere length

Identifiers

PMID30375983
PMCPMC6224259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.